Grup de recerca de biomarcadors en càncer (GReBiC)
- Nombre de publicacions
- 495
Publicacions
-
Valladares-Ayerbes, M; Fonseca, MT; de Prado, JV; Inga-Saavedra, E; Gil, S; Suarez, BG; Garcia-Paredes, B; Salud, A; Herrero, FR; Fernandez, MS; Garcia-Alfonso, P; Lopez-Lopez, R; Monteagudo, RF; Sastre, J; Diaz-Rubio, E; Aranda, E
Circulating RNA detection, circulating tumor cells count, and molecular tumor profiling in a cohort of untreated metastatic colorectal cancer: A prospective multicenter ancillary study to the randomized VISNU trials
ANNALS OF ONCOLOGY 32 131-132. .
-
Mummadi SR; Porcel JM
Ambulatory management of secondary spontaneous pneumothorax: a mirage, or a solution on the horizon?
EUROPEAN RESPIRATORY JOURNAL 57 -. .
-
Sorolla MA; Sorolla A; Parisi E; Salud A; Porcel JM
Diving into the Pleural Fluid: Liquid Biopsy for Metastatic Malignant Pleural Effusions.
Cancers 13 -. .
-
Vicente-Pascual M; Molins-Rojas C; Rosas-Soto K; Murata-Yonamine EP; Vázquez-Justes D; Purroy F; Traveset-Maeso A
Bilateral Optic Neuritis Secondary to Immune Etiology by anti-PD-L1 Antibody.
JOURNAL OF NEURO-OPHTHALMOLOGY 41 177-179. .
-
Porcel JM; Murata P; Porcel L; Bielsa S; Pardina M; Salud A
Prevalence, clinical characteristics, and outcome of pleural effusions in ovarian cancer.
Pleura and Peritoneum 6 75-81. .
-
Porcel JM
Dr. Richard W. Light (1942-2021).
ARCHIVOS DE BRONCONEUMOLOGIA -. .
-
Vidal, J; Casadevall, D; Bellosillo, B; Pericay, C; Garcia-Carbonero, R; Losa, F; Layos, L; Alonso, V; Capdevila, J; Gallego, J; Vera, R; Salud, A; Martin-Richard, M; Nogue, M; Cillan, E; Maurel, J; Faull, I; Raymond, V; Fernandez-Martos, C; Montagut, C
Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD1402 Trial
CLINICAL CANCER RESEARCH 27 2890-2898. .
-
Bagueste, G; Porcel, JM
Pleural Infection Caused by Nocardia farcinica: Two Cases and Review of the Literature
CUREUS JOURNAL OF MEDICAL SCIENCE 13 -. .
-
Martin, M; Zielinski, C; Ruiz-Borrego, M; Carrasco, E; Turner, N; Ciruelos, EM; Munoz, M; Bermejo, B; Margeli, M; Anton, A; Kahan, Z; Csoszi, T; Casas, MI; Murillo, L; Morales, S; Alba, E; Gal-Yam, E; Guerrero-Zotano, A; Calvo, L; de la Haba-Rodriguez, J; Ramos, M; Alvarez, I; Garcia-Palomo, A; Bartlett, CH; Koehler, M; Caballero, R; Corsaro, M; Huang, X; Garcia-Saenz, JA; Chacon, JI; Swift, C; Thallinger, C; Gil-Gil, M
Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARL
ANNALS OF ONCOLOGY 32 488-499. .
-
Sastre, J; Garcia-Alfonso, P; Vieitez, JM; Cano, MT; Rivera, F; Reina-Zoilo, JJ; Salud-Salvia, A; Quintero, G; Robles-Diaz, L; Safont, MJ; La Casta, A; Gil, S; Polo, E; Asensio-Martinez, E; Garcia-Paredes, B; Lopez, RL; Guillot, M; Valladares-Ayerbes, M; Aranda, E; Diaz-Rubio, E
Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and < 3 baseline circulating tumour cells: the randomised phase II VISNU-2 study
ESMO Open 6 -. .
-
Cudos, AG; Murillo, SM; Subirats, OP; Galindo, AR; Rodriguez, JV; Guzman, DRS; Villellas, FV; Morales, CC; Olive, JM; Martinez, EI
Assesment of endocrine sensitivity in primary breast cancer through RS Score and changes in the proliferation index KI67
BREAST 56 52-53. .
-
Golden E; Rashwan R; Woodward EA; Sgro A; Wang E; Sorolla A; Waryah C; Tie WJ; Cuyàs E; Ratajska M; Kardas I; Kozlowski P; Johnstone EKM; See HB; Duffy C; Parry J; Lagerborg KA; Czapiewski P; Menendez JA; Gorczynski A; Wasag B; Pfleger KDG; Curtis C; Lee BK; Kim J; Cursons J; Pavlos NJ; Biernat W; Jain M; Woo AJ; Redfern A; Blancafort P
The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer.
Nature Communications 12 1920-1920. .
